Karen Van Nuys, PhD, is the executive director of the Value of Life Sciences Innovation program and a fellow at the USC Schaeffer Center. Her recent research focuses on the social value of novel therapies, the flow of funds in the pharmaceutical distribution chain, and the impact of supply chain intermediary practices such as spread pricing and copay clawbacks on the utilization and cost of prescription drugs. Her work has been published in leading journals in economics, medicine, finance and health policy.
She has held positions across both industry and academia, including as principal and priority service offering director at Booz Allen Hamilton, senior research economist at Precision Health Economics, national fellow at the Hoover Institution and an assistant professor at the Simon School of Business at the University of Rochester. She has consulted with Fortune 50 companies ranging from insurance providers and life sciences companies to automotive manufacturers and media conglomerates. She received her PhD in economics from Stanford University, and her MA and BA degrees from the University of California, San Diego.